I have posted the first of a four part interview with Dr. Tom Kipps from ASH 2012 on my blog ( bkoffman.blogspot.com ) where her discusses Bcl-2 and ABT-199. I follow that up with the news and my take on the suspended trials due to two deaths from tumor lysis syndrome.
Doing these trials right is critical. Not following each and every tedious slow step in the development process is a good way to kill a great drug and maybe put some patients at risk on the way.
Stay strong. We are all in this together